Filter
755
Text search:
health
recipient
Featured
Recommendations
54
New Publications
219
Language
Document type
No document type
431
Studies & Reports
147
Guidelines
82
Manuals
41
Strategic & Response Plan
22
Fact sheets
18
Training Material
7
Situation Updates
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
Global
57
India
33
Kenya
24
Western and Central Europe
19
Sierra Leone
16
Nepal
16
Liberia
14
South Africa
14
Myanmar / Burma
14
Nigeria
13
Ethiopia
12
Uganda
12
Tanzania
10
Africa
10
Eastern Europe
10
Philippines
9
Zambia
9
Syria
8
Ukraine
8
Bangladesh
7
Malawi
7
Latin America and the Carribbean
7
Asia
7
Congo, Democratic Republic of
6
Ghana
6
Pakistan
6
Rwanda
6
Guinea
5
China
5
Namibia
5
Zimbabwe
4
Germany
4
Indonesia
4
Lesotho
4
Yemen
4
West and Central Africa
4
South–East Asia Region
4
Haiti
3
Cambodia
3
Colombia
3
Middle East and North Africa
3
Venezuela
3
Russia
3
Cameroon
2
Jordan
2
Thailand
2
Mozambique
2
Eswatini/ Swaziland
2
Brazil
2
North Macedonia
2
Botswana
2
Bhutan
2
Albania
2
Moldova
2
Georgia
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
USA
1
South Sudan
1
Afghanistan
1
Lebanon
1
Singapore
1
Central African Republic
1
Peru
1
Libya
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Canada
1
Tajikistan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
242
Key Resources
50
Clinical Guidelines
32
Public Health
28
Women & Child Health
20
Capacity Building
10
Pharmacy & Technologies
10
Annual Report MEDBOX
1
Toolboxes
COVID-19
80
Health Financing Toolbox
75
HIV
52
TB
44
Pharmacy
32
Mental Health
29
Disability
27
Rapid Response
27
Ebola
22
Caregiver
20
Refugee
19
Planetary Health
18
Conflict
17
Natural Hazards
12
Global Health Education
12
NTDs
12
AMR
6
Polio
5
Zika
5
Social Ethics
4
NCDs
3
Health Financing
2
Cholera
1
Typhoon
1
Specific Hazards
1
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta
...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass
...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up
...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at
...
As a Frontline Health Care Worker or a Vaccinator, you need to counsel pregnant women about the availability, value and precautions regarding the COVID-19 vaccine. This note provides you with the information that you need to educate and support preg
...
updated version: 04/10/2021
Information about vaccine administration
This guideline aims to improve the quality of donations and the management thereof and serve as the basis for policies of the State and other organizations in the giving and receiving of donations of medicines, medical devices and IVDs.
Over the last three or four decades, there has been an enorm
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
A rapid review of evidence on the managing the risk of disease emergence in the wildlife trade - World Animal Health Organization (OIE)
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Annex 5, WHO Technical Report Series 1010, 2018
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
